Wilson Liao, MD
Enriched profileProfessor and Associate Vice Chair of Research in the UCSF Department of Dermatology · University of California, San Francisco
Wilson Liao is Professor and Associate Vice Chair of Research in the UCSF Department of Dermatology at University of California, San Francisco. OpenAlex indexes 441 publications with 16,788 citations (h-index 57); ClinicalTrials.gov lists 6 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.
Data verified 18 Oct 2026
Overview
Updated 18 Oct 2026
Wilson Liao, M.D., is Professor and Associate Vice Chair of Research in the UCSF Department of Dermatology at University of California, San Francisco. The public record shows 441 publications with 16,788 citations (h-index 57), centered on Psoriasis: Treatment and Pathogenesis, Dermatology and Skin Diseases, Spondyloarthritis Studies and Treatments. It also documents an investigator role on 6 registered clinical trials, industry payments reported by 2 companies, 6 NIH-funded awards (2010–2026).
- Most recent indexed publication: 2026 · The Journal of dermatological treatment
- Top research focus: Psoriasis: Treatment and Pathogenesis
- 6 registered trials on ClinicalTrials.gov
- Open Payments reporting from 2 companies
Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 55 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 165.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 18 Oct 2026
Listed as an investigator on 6 registered studies on ClinicalTrials.gov. The most recent:
- The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Sponsor: University of California, San Francisco
- Guselkumab Immunogenetics
Sponsor: University of California, San Francisco
- Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use
Sponsor: University of California, San Francisco
Industry payments
Updated 18 Oct 2026
2 companies reported payments to CMS in program years 2023–2025. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20251 payment
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20231 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
43.7%Interleukin-23 Antagonist13.2%Skyrizi Pen51%Tremfya49%Part D<11 patientsInterleukin-17A Antagonist11.2%Taltz Autoinjector54%Cosentyx Unoready Pen24%Taltz Syringe22%Part D<11 patients+ 6 more classes in this area
Dermatology
22.5%Corticosteroid11.9%Triamcinolone Acetonide100%Part D≥33 patientsInterleukin-4 Receptor alpha Antagonist4.5%Dupixent Syringe100%Part D<11 patients+ 2 more classes in this area
Sensory organs
20.9%Corticosteroid20.9%Clobetasol Propionate69%Hydrocortisone18%Desonide14%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 18 Oct 2026
6 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
University of Rochester
FY2026$4,048,118UC2AR081029 - Multi-racial genetic analysis of hidradenitis suppurativa
University of California, San Francisco
FY2025$665,897R01AR078688
Publications
Updated 18 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Increasing formulary adoption of adalimumab biosimilars and differential cost-sharing in Medicare Part D plans.
The Journal of dermatological treatment
Article2026 - Estimated cost savings and formulary coverage barriers in biosimilar adoption.
The Journal of dermatological treatment
Article2026 - GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.
The Journal of rheumatology
Conference Proceedings2026 - Exploring the Gut Microbiome's Association in Psoriasis and Psoriatic Arthritis: A Scoping Review.
Journal of psoriasis and psoriatic arthritis
Review2026 - GRAPPA 2025 Collaborative Research Network Meeting: Difficult-to-Treat Psoriatic Arthritis and Future Strategies for Curing Psoriasis.
The Journal of rheumatology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Influence of diet on the gut microbiome and implications for human healthArticle2,593 citations2017
- 02Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathwaysArticle1,411 citations2009
- 03Regulatory T Cells in Skin Facilitate Epithelial Stem Cell DifferentiationArticle672 citations2017
- 04A Genome-Wide Association Study of Psoriasis and Psoriatic Arthritis Identifies New Disease LociArticle663 citations2008
- 05
Network
Updated 18 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 18 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Mentions by others
where others cite or feature them- Other
amp.profiles.ucsf.edu/wilson.liao
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗ - Other
psoriasis.org/staff/wilson-liao-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasis.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 18 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ucsfhealth.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →amp.profiles.ucsf.edu ↗
Editorial & leadership roles
journal and society appointments- Chair
National Psoriasis Foundation Scientific Advisory Committee
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →psoriasis.org ↗ - Councilor
International Psoriasis Council
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →conference.ifpa-pso.com ↗ - Co-Chair
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis Research Committee
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jrheum.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Emmanuelle Waubant, MD
University of California, San Francisco
Peter Ganz, MD
University of California, San Francisco
Joel Palefsky, MD
University of California, San Francisco
Peter Hunt, MD
University of California, San Francisco
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center